Total Payments
$2,182
2024 Payments
$896.71
Companies
19
Transactions
189
Medicare Patients
2,413
Medicare Billing
$212,833
Payment Breakdown by Category
Food & Beverage$2,168 (99.4%)
Education$13.89 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,168 | 188 | 99.4% |
| Education | $13.89 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $528.47 | 100 | $0 (2024) |
| Amgen Inc. | $337.70 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $333.93 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $167.14 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $132.49 | 8 | $0 (2024) |
| Boston Scientific Corporation | $130.24 | 4 | $0 (2024) |
| PFIZER INC. | $103.80 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $98.26 | 6 | $0 (2024) |
| Abbott Laboratories | $55.69 | 3 | $0 (2024) |
| Novo Nordisk Inc | $48.24 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $896.71 | 88 | Novartis Pharmaceuticals Corporation ($259.72) |
| 2023 | $460.01 | 46 | Novartis Pharmaceuticals Corporation ($132.74) |
| 2022 | $540.64 | 35 | Novartis Pharmaceuticals Corporation ($136.01) |
| 2021 | $284.98 | 20 | Janssen Pharmaceuticals, Inc ($136.21) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Heart Failure | ||||||
| 12/18/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Heart Failure | ||||||
| 12/15/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Genetic Disease | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.09 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $0.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 690 | 988 | $413,815 | $57,276 |
| 2022 | 5 | 674 | 966 | $390,023 | $58,567 |
| 2021 | 4 | 549 | 821 | $366,529 | $60,106 |
| 2020 | 4 | 500 | 638 | $246,748 | $36,884 |
Total Patients
2,413
Total Services
3,413
Medicare Billing
$212,833
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 456 | 625 | $346,875 | $46,457 | 13.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 98 | $32,242 | $5,157 | 16.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $25,004 | $3,264 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 127 | 215 | $1,290 | $1,264 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $8,404 | $1,133 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 439 | 615 | $305,227 | $45,972 | 15.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 127 | $41,783 | $5,806 | 13.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 39 | $34,827 | $5,153 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 21 | $7,202 | $1,152 | 16.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 102 | 164 | $984.00 | $482.97 | 49.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 429 | 648 | $298,728 | $50,509 | 16.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 69 | 120 | $39,480 | $5,726 | 14.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 20 | $17,860 | $2,681 | 15.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 33 | $10,461 | $1,190 | 11.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 237 | 316 | $134,932 | $19,938 | 14.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 183 | 217 | $63,798 | $9,706 | 15.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 78 | $25,662 | $3,676 | 14.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 26 | 27 | $22,356 | $3,564 | 15.9% |
About Ashley Rees, APRN
Ashley Rees, APRN is a Family healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2019. The National Provider Identifier (NPI) number assigned to this provider is 1063977627.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Rees, APRN has received a total of $2,182 in payments from pharmaceutical and medical device companies, with $896.71 received in 2024. These payments were reported across 189 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,168).
As a Medicare-enrolled provider, Rees has provided services to 2,413 Medicare beneficiaries, totaling 3,413 services with total Medicare billing of $212,833. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Springfield, IL
- Active Since 02/07/2019
- Last Updated 05/20/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1063977627
Products in Payments
- LEQVIO (Drug) $351.99
- Repatha (Biological) $337.70
- XARELTO (Drug) $333.93
- ENTRESTO (Drug) $176.48
- VERQUVO (Drug) $167.14
- ELIQUIS (Drug) $130.61
- WATCHMAN Access System (Device) $92.02
- CAMZYOS (Drug) $71.45
- FARXIGA (Drug) $58.07
- Wegovy (Drug) $48.24
- LifeVest (Device) $41.05
- WAINUA (Drug) $37.16
- Vascepa (Drug) $32.95
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $32.26
- FUROSCIX (Drug) $31.87
- ZIO XT Patch (Device) $24.65
- JARDIANCE (Drug) $24.42
- CARDIOMEMS (Device) $23.43
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $22.91
- ANDEXXA (Biological) $22.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Springfield
Mrs. Erin Duvall, Aprn, Fnp-C, Pmhnp-B, APRN, FNP-C, PMHNP-B
Family — Payments: $207,898
Family $207,898
Laura Hediger, Fnp, FNP
Family — Payments: $62,482
Family $62,482
Jenna Pelc, Np, NP
Family — Payments: $50,048
Family $50,048
Emily Wouk, Msn, Fpmhnp, Fnp, MSN, FPMHNP, FNP
Family — Payments: $41,104
Family $41,104
Mrs. Kristie Harrington, Fnp-Bc, FNP-BC
Family — Payments: $17,270
Family $17,270
Karen Smith, Crnp, CRNP
Family — Payments: $13,950
Family $13,950